Closing prices for 09 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
No events for this security recently.
Zai Lab Limited (ZLAB) is a public company in the healthcare sector. Its depositary receipts trade on NASDAQ.
Over the trailing twelve months as reported to 2026-03-31, revenue was 453.3m $, net income was -178.1m $. Incorporated in KY.
This summary is compiled automatically from SEC filings and exchange data.
Address:899 HALEI ROAD BUILDING B, PUDONG, SHANGHAI
Zai Lab Limited trades on Nasdaq under the ticker ZLAB. The company belongs to the Health care sector. The trading history on this page starts on 20 September 2017.
Over the past 52 weeks ZLAB has traded between 15.96 $ and 33.65 $. As of 09 October 2026 the price stood 51.05 % of the way from the 52-week low to the high.
Over one year ZLAB shares fell 25.82 %; over six months they rose 20.84 %. Volatility over 90 days is 48.64 %. Dividends are not included: this is price change only, as of 09 October 2026.
Zai Lab Limited reported revenue of 453M $ and a net loss of 178M $ over the last four quarters. Net margin is −39.29 %. Revenue changed by +8.36 % year over year. Earnings per share are −0.17 $.
ZLAB has a return on equity of −26.91 %, above the sector median of −41.68 %. Return on assets is −16.26 %, above the sector median of −32.11 %. Operating margin is −53.50 %, below the sector median of −26.84 %.
| Security | Price, $ | Day change | Turnover 30d, $ |
|---|---|---|---|
| GSKGSK plc | 46.50 | −0.09 % | 190M |
| ONCBeOne Medicines Ltd. | 354.47 | +1.24 % | 135M |
| ABVXAbivax SA | 88.15 | −1.01 % | 135M |
| SNYSanofi | 40.07 | −0.40 % | 115M |
| GMABGenmab A/S | 37.07 | +2.83 % | 111M |
| GPCRStructure Therapeutics Inc. | 25.54 | −0.51 % | 49M |
| LEGNLegend Biotech Corporation | 18.62 | −0.48 % | 40M |
| BLTEBelite Bio, Inc | 154.49 | +1.29 % | 34M |
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 24.82 | 25.92 | 24.35 | 24.99 | 1M |
| 08 October 2026 | 24.33 | 24.94 | 23.76 | 24.81 | 979,100 |
| 07 October 2026 | 25.20 | 25.45 | 24.73 | 25.31 | 290,200 |
| 06 October 2026 | 26.80 | 26.92 | 25.51 | 25.58 | 1M |
| 05 October 2026 | 24.44 | 25.65 | 24.33 | 25.62 | 787,300 |
| 02 October 2026 | 24.86 | 24.86 | 23.71 | 24.33 | 951,800 |
| 01 October 2026 | 26.30 | 26.52 | 25.41 | 25.50 | 545,200 |
| 30 September 2026 | 26.35 | 26.68 | 26.00 | 26.34 | 830,800 |
| 29 September 2026 | 26.22 | 26.22 | 25.37 | 25.93 | 549,100 |
| 28 September 2026 | 25.41 | 26.50 | 25.06 | 25.69 | 884,700 |
| 25 September 2026 | 25.21 | 25.54 | 24.95 | 24.98 | 298,100 |
| 24 September 2026 | 25.42 | 25.42 | 24.81 | 25.28 | 585,300 |
| 23 September 2026 | 26.51 | 26.80 | 26.29 | 26.44 | 791,600 |
| 22 September 2026 | 26.89 | 27.05 | 26.37 | 26.41 | 996,400 |
| 21 September 2026 | 26.64 | 26.72 | 26.16 | 26.43 | 1M |
| 18 September 2026 | 26.26 | 27.14 | 25.60 | 25.70 | 887,500 |
| 17 September 2026 | 25.25 | 26.07 | 25.03 | 25.81 | 673,100 |
| 16 September 2026 | 24.90 | 25.32 | 24.42 | 24.67 | 1M |
| 15 September 2026 | 24.49 | 25.00 | 24.49 | 24.80 | 937,100 |
| 14 September 2026 | 24.30 | 24.65 | 23.89 | 24.58 | 1M |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.